Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy.
Saved in:
| Title: | Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy. |
|---|---|
| Authors: | Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida. Electronic address: aasha.hoogland@moffitt.org., Barata A; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Li X; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Irizarry-Arroyo N; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Jain MD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Welniak T; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Rodriguez Y; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Oswald LB; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Gudenkauf LM; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Chavez JC; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Khimani F; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Lazaryan A; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Liu HD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Nishihori T; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Pinilla-Ibarz J; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Shah BD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Crowder SL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Parker NH; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Carson TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Vinci CE; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Pidala JA; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Logue J; Moffitt Malignant Hematology & Cellular Therapy, Memorial Healthcare System, Pembroke Pines, Florida., Locke FL; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Jim HSL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2024 Dec; Vol. 30 (12), pp. 1219.e1-1219.e11. Date of Electronic Publication: 2024 Sep 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
